| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 439.414 | 436.885 | 406.541 | 379.311 | 343.906 | 413.648 | 399.971 | 451.983 | 503.472 | 545.573 |
| Total Income - EUR | 441.462 | 437.389 | 409.272 | 379.782 | 343.908 | 418.836 | 400.174 | 454.576 | 505.823 | 546.672 |
| Total Expenses - EUR | 430.679 | 421.010 | 399.429 | 374.800 | 337.923 | 403.022 | 381.215 | 436.192 | 484.282 | 540.812 |
| Gross Profit/Loss - EUR | 10.782 | 16.379 | 9.843 | 4.982 | 5.985 | 15.814 | 18.959 | 18.384 | 21.541 | 5.861 |
| Net Profit/Loss - EUR | 8.863 | 13.390 | 7.986 | 3.422 | 4.745 | 13.754 | 15.782 | 15.719 | 18.488 | 3.330 |
| Employees | 9 | 9 | 9 | 8 | 7 | 7 | 7 | 7 | 6 | 6 |
Check the financial reports for the company - Belladonna Farmacom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.427 | 20.262 | 20.866 | 22.895 | 48.061 | 42.199 | 45.636 | 46.892 | 52.199 | 83.243 |
| Current Assets | 150.122 | 134.480 | 115.823 | 96.455 | 102.035 | 119.492 | 118.056 | 127.926 | 155.199 | 163.669 |
| Inventories | 71.815 | 79.133 | 76.035 | 54.847 | 72.896 | 80.127 | 73.638 | 83.785 | 100.742 | 112.052 |
| Receivables | 27.640 | 12.847 | 30.043 | 38.145 | 25.946 | 29.813 | 37.300 | 39.853 | 48.244 | 48.237 |
| Cash | 50.667 | 42.501 | 9.745 | 3.463 | 3.193 | 9.552 | 7.118 | 4.289 | 6.213 | 3.381 |
| Shareholders Funds | 96.247 | 96.349 | 92.749 | 77.503 | 73.870 | 81.872 | 84.348 | 81.118 | 97.163 | 97.764 |
| Social Capital | 227 | 225 | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | 71.108 | 58.605 | 44.364 | 42.567 | 77.081 | 80.619 | 80.174 | 93.977 | 110.589 | 149.861 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Belladonna Farmacom Srl